Health Care: Drugs

Dr Reddy's Laboratories Ltd (RDY: NYSE)

$41.76 0.24 | 0.58%
07/25/17 - 04:02 PM ET
Company Income Statement
Mar 2017 Mar 2016 Mar 2015 Mar 2014
Sales 2.17B 2.33B 2.37B 2.21B
Cost of Sales 963.03M 785.79M 874.43M 823.18M
Gross Operating Profit 1.21B 1.54B 1.50B 1.39B
Selling, General, and Administrative Expenses 715.06M 688.27M 680.93M 648.06M
Research & Development 301.48M 268.58M 279.01M 207.24M
Operating Income before D & A (EBITDA) 191.72M 587.26M 535.17M 530.07M
Depreciation & Amortization n.a. 154.37M 129.52M 118.74M
Interest Income 12.43M 21.07M 16.97M 18.13M
Other Income - Net 0.00 -47.02M 33.42M 33.50M
Special Income / Charges 16.42M 10.77M 8.63M 0.00
Total Income Before Interest Expenses (EBIT) 225.95M 421.17M 467.79M 465.87M
Interest Expense 0.00 12.44M 17.46M 21.29M
Pre-Tax Income 225.95M 408.73M 450.33M 444.59M
Income Taxes 40.31M 107.33M 95.68M 85.12M
Minority Interest 0.00 0.00 0.00 -50.13K
Net Income From Continuing Operations 185.64M 301.40M 354.64M 359.47M
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations 185.64M 301.40M 354.64M 359.47M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income 185.64M 301.40M 354.64M 359.52M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
169.22M 290.63M 346.01M 359.47M
Preferred Dividends
Net Income Available To Common 0.00 301.40M 354.64M 359.47M
Basic EPS from Continuing Ops. 1.12 1.77 2.08 2.11
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations 1.12 1.77 2.08 2.11
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total 1.12 1.77 2.08 2.11
Basic Normalized Net Income/Share 1.02 1.70 2.03 2.11
EPS fr Continuing Ops. 1.11 1.76 2.07 2.11
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. 1.11 1.76 2.07 2.11
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total 1.11 1.76 2.07 2.11
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
1.01 1.70 2.02 2.11
Dividends Paid per Share 0.30 0.31 0.29 0.26

Portfolios with RDY

Latest RDY Headlines from TheStreet

More Financial News for RDY

Press Releases for RDY

See All Press Releases
brokerage partners
watch thestreet tv
No Videos Found
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter